Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF
Status:
Not yet recruiting
Trial end date:
2033-04-01
Target enrollment:
Participant gender:
Summary
The primary objective is to demonstrate the safety and efficacy of the implantation of the
LAmbre PlusTM device in patients with large or irregularly shaped appendages with
non-valvular atrial fibrillation who are at increased risk for stroke and systemic embolism
compared to oral anticoagulation (OAC).